Skip to main content

Find Clinical Trials

Home
Conditions
Migraine Disorders

Clinical trial condition

Migraine Disorders

Explore clinical trials studying Migraine Disorders. Study availability and eligibility vary by location and protocol.

165 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Migraine Disorders trial results

Completed

Use Of GW274150 In The Prophylactic Treatment Of Migraine

NCT00242866

Conditions: Brain Diseases, Central Nervous System Diseases, Headache Disorders, +3 more
Locations: GSK Investigational Site Antwerp, Belgium

GSK Investigational Site Leuven, Belgium

GSK Investigational Site Liège, Belgium

GSK Investigational Site Glostrup Municipality, Denmark

View all 62 locations

View Trial Details

Completed

Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With Migraine

NCT01828684

Conditions: Brain Diseases, Central Nervous System Diseases, Eye Diseases, +12 more
Locations: John A Moran Eye Center; University of Utah Hospitals and Clinics Salt Lake City, Utah, United States

View Trial Details

Completed

A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache

NCT01946126

Conditions: Brain Diseases, Central Nervous System Diseases, Headache, +8 more
Locations: Raleigh, North Carolina, United States

View Trial Details

Completed

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

NCT00792103

Conditions: Brain Diseases, Central Nervous System Diseases, Headache Disorders, +3 more
Locations: Phoenix, Arizona, United States

Little Rock, Arkansas, United States

Newport Beach, California, United States

San Francisco, California, United States

View all 34 locations

View Trial Details

Completed

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

NCT00724815

Conditions: Brain Diseases, Central Nervous System Diseases, Headache Disorders, +3 more
Locations: Phoenix, Arizona, United States

Little Rock, Arkansas, United States

Newport Beach, California, United States

San Francisco, California, United States

View all 34 locations

View Trial Details

Completed

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

NCT00806546

Conditions: Brain Diseases, Central Nervous System Diseases, Headache Disorders, +3 more
Locations: Phoenix, Arizona, United States

Scottsdale, Arizona, United States

Irvine, California, United States

Newport Beach, California, United States

View all 31 locations

View Trial Details

Completed

Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period

NCT00723983

Conditions: Brain Diseases, Central Nervous System Diseases, Headache Disorders, +3 more
Locations: MD Clinic Hallandale, Florida, United States

View Trial Details

Completed

Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers

NCT00720018

Conditions: Brain Diseases, Central Nervous System Diseases, Headache Disorders, +3 more
Locations: Prism Research Saint Paul, Minnesota, United States

View Trial Details

Completed

Lippia Alba for Migraine Prophylaxis and Treatment

NCT01259947

Conditions: Brain Diseases, Central Nervous System Diseases, Headache, +8 more
Locations: Naturoterapia Sinho Mariano Araxá, Minas Gerais, Brazil

View Trial Details

Completed

Special Drug Use Investigation for AMERGE® Tablet (Long-term)

NCT01332383

Conditions: Brain Diseases, Central Nervous System Diseases, Headache Disorders, +3 more
Locations: Not specified

View Trial Details